<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03904212</url>
  </required_header>
  <id_info>
    <org_study_id>Adiposetissue_CD_Fistula_RCT</org_study_id>
    <nct_id>NCT03904212</nct_id>
  </id_info>
  <brief_title>Adipose Tissue Injection in Perianal Fistulas in Crohn´s Disease</brief_title>
  <official_title>Treatment of Perianal Fistulas in Crohn´s Disease Patients With Autologous Adipose Tissue Injection: A Randomized and Placebocontrolled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized and placebo controlled study investigates the efficacy of injections with
      freshly harvested autologous adipose tissue in CD patients with complex perianal fistulas
      refractory to standard surgical and/or medical treatment. 140 CD patients will be included
      and randomized to either treatment with freshly harvested autologous adipose tissue or
      placebo (saline). Primary outcome measures are clinical healing 6 months after treatment
      evaluated by clinical examination and pelvic MRI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Injection with freshly harvested autologous adipose tissue has been reported to be an
      efficient treatment of perianal fistulas in patients with Crohn´s Disease (CD). In a
      prospective observational study 57 % of 21 patients with complex fistulas refractory to
      combined surgical and/or medical treatment achieved complete clinical healing of the treated
      fistulas from one to three injections.

      This randomized and placebo controlled study aims to confirm the efficacy of injections with
      freshly harvested autologous adipose tissue in CD patients with perianal fistulas. 140 CD
      patients with complex perianal fistulas refractory to standard surgical and/or medical
      treatment will be included and randomized to either treatment with freshly harvested
      autologous adipose tissue or placebo (saline). Clinical evaluation of the treatment efficacy
      will also be performed in a blinded manner.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 27, 2019</start_date>
  <completion_date type="Anticipated">March 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete clinical healing 6 months after treatment</measure>
    <time_frame>6 months after treatment</time_frame>
    <description>No visible external opening or palpabel internal opening, no symptoms in the form of secretion and pelvic MR with out sign of fluid tracts.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical healing 3 months after treatment</measure>
    <time_frame>3 months after treatment</time_frame>
    <description>o visible external opening or palpabel internal opening, no symptoms in the form of secretion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Partial healing 6 months after treatment</measure>
    <time_frame>6 months</time_frame>
    <description>Partial healing evaluated by pelvec MRI 6 months after treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in symptoms 3 months after treatment</measure>
    <time_frame>3 months</time_frame>
    <description>Change in Perianal Disease Activity Index (PDAI) 3 months after treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in symptoms 6 months after treatment</measure>
    <time_frame>6 months</time_frame>
    <description>Change in Perianal Disease Activity Index (PDAI) 6 months after treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in inconsistency 6 months after treatment</measure>
    <time_frame>6 months</time_frame>
    <description>Change in inconsistency score (St.Marks) 6 months after treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Crohn Disease</condition>
  <condition>Perianal Fistulas</condition>
  <condition>Cell- and Tissue-Based Therapy</condition>
  <condition>Treatment</condition>
  <arm_group>
    <arm_group_label>Adipose tissue injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be treated with freshly harvested autologous adipose tissue</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will be treated with saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adipose tissue injection</intervention_name>
    <description>Injection with freshly harvested autologous adipose tissue</description>
    <arm_group_label>Adipose tissue injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>injection with saline</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with Crohn´s Disease

          -  Perianal fistula with out branching or cavities with one external and one internal
             opening, which due to the risk for development of incontinence is not suitable for
             lay-open procedure, meaning: 1) all anterior interspinchteric and low transpinchteric
             (involving&lt;1/3 of spinchter) in women 2) high interspinchteric fistulas 3) high
             transspinchteric (&gt;1/3 of sphincter), suprasphincteric and ekstrasphincteric fistulas
             4) intersphincteric or low transsphincteric fistula in patients with fecal
             incontinence and/or fecal urge.

          -  no or minimal luminal disease activity by colonoscopy &lt; 3 months before treatment
             defined by Simple Endoscopic Severity for Crohn´s Disease&lt;3

          -  Prior optimal medical treatment for fistulas (immunmodulators, antibiotics and/or
             anti-TNF-alfa treatment) with out achieving fistula healing

          -  Treatment with seton for a minimum of 6 weeks

          -  Speaks and understand Danish

        Exclusion Criteria:

          -  Pregnancy

          -  Changes in immunmodulator or anti-TNFalfa treatment &lt; 12 weeks

          -  Anovaginal fistulas

          -  Rectal or anal stenosis

          -  Active proctitis

          -  Stoma

          -  Previous surgery for fistulas besides simpel drainage or seton

          -  Smoker

          -  Insulin-dependent diabetes, conditions inducing defective immunity, pelvic radiation

          -  pelvic MRI contraindicated
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lilli Lundby, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anders Dige, MD</last_name>
    <phone>+45 5190 3619</phone>
    <email>andedige@rm.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anders Dige, MD</last_name>
      <phone>+45 5190 3619</phone>
      <email>andedige@rm.dk</email>
    </contact>
    <contact_backup>
      <last_name>Lilli Lundby, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>April 3, 2019</study_first_submitted>
  <study_first_submitted_qc>April 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2019</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Aarhus</investigator_affiliation>
    <investigator_full_name>Lilli Lundby</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Rectal Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 1, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/12/NCT03904212/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

